Abstract
Hemminki and Herxheimer recently asked whether drug information should be treated as an integral part of health care.2 It is difficult to see how it could be otherwise, yet discussion of regulation and related issues throws up a catalogue of tensions and contradictions.3 Patients need information about medicines to inform their choices about health care. Yet the imperatives of commercial confidentiality and protection of academic, professional, and business interests reduce consumers' ability to find out about the history and potential benefits or disbenefits of both prescription only and over the counter medicines.

This publication has 0 references indexed in Scilit: